Carbon Medical Technologies, Inc. (FKA Advanced UroScience, Inc.) was formed in 1994 for the purpose of developing permanent human implantable products utilizing pyrolytic carbon. Carbon is a naturally occurring element in the human body. As a result, pyrolytic carbon is not recognized by the human body as foreign, thus rendering it ideal as a permanent implant material. Carbon Medical Technologies (CMT) operates a fully functional pyrolytic carbon-coating facility, one of five known to exist in the world.
The CMT business model is to design, develop and manufacture pyrolytic carbon-based implants, successfully navigate the regulatory process and bring the products to market. This could happen through divesting or licensing products for commercialization, entering into a distribution agreement, or direct sales.